489 related articles for article (PubMed ID: 16630019)
1. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.
Khan R; Sheppard R
Immunology; 2006 May; 118(1):10-24. PubMed ID: 16630019
[TBL] [Abstract][Full Text] [Related]
2. The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation.
Li X; Ma C; Dong J; Liu X; Long D; Tian Y; Yu R
Med Hypotheses; 2008; 70(2):317-9. PubMed ID: 17689021
[TBL] [Abstract][Full Text] [Related]
3. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
4. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
[TBL] [Abstract][Full Text] [Related]
5. Role of miR-24, Furin, and Transforming Growth Factor-β1 Signal Pathway in Fibrosis After Cardiac Infarction.
Chen Z; Lu S; Xu M; Liu P; Ren R; Ma W
Med Sci Monit; 2017 Jan; 23():65-70. PubMed ID: 28055991
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease.
Xiao H; Lei H; Qin S; Ma K; Wang X
Clin Cardiol; 2010 Mar; 33(3):149-56. PubMed ID: 20235205
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
8. TGF-β
Salvarani N; Maguy A; De Simone SA; Miragoli M; Jousset F; Rohr S
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004567. PubMed ID: 28500173
[TBL] [Abstract][Full Text] [Related]
9. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
10. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β.
Yeh YH; Kuo CT; Chang GJ; Qi XY; Nattel S; Chen WJ
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):790-8. PubMed ID: 23884197
[TBL] [Abstract][Full Text] [Related]
13. Absence of natriuretic peptide clearance receptor attenuates TGF-β1-induced selective atrial fibrosis and atrial fibrillation.
Rahmutula D; Zhang H; Wilson EE; Olgin JE
Cardiovasc Res; 2019 Feb; 115(2):357-372. PubMed ID: 30239604
[TBL] [Abstract][Full Text] [Related]
14. HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-β1 and can be suppressed by exogenous carbon monoxide.
Laurence J; Elhadad S; Robison T; Terry H; Varshney R; Woolington S; Ghafoory S; Choi ME; Ahamed J
PLoS One; 2017; 12(10):e0187185. PubMed ID: 29088262
[TBL] [Abstract][Full Text] [Related]
15. Examining potential therapies targeting myocardial fibrosis through the inhibition of transforming growth factor-beta 1.
Khan R
Cardiology; 2007; 108(4):368-80. PubMed ID: 17308385
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation.
Xiao M; Zhang M; Bie M; Wang X; Guo J; Xiao H
Cardiology; 2020; 145(7):446-455. PubMed ID: 32516780
[TBL] [Abstract][Full Text] [Related]
17. Potential role of MG53 in the regulation of transforming-growth-factor-β1-induced atrial fibrosis and vulnerability to atrial fibrillation.
Guo J; Jia F; Jiang Y; Li Q; Yang Y; Xiao M; Xiao H
Exp Cell Res; 2018 Jan; 362(2):436-443. PubMed ID: 29233682
[TBL] [Abstract][Full Text] [Related]
18. Circulated TGF-β1 and VEGF-A as Biomarkers for Fabry Disease-Associated Cardiomyopathy.
Ivanova MM; Dao J; Slayeh OA; Friedman A; Goker-Alpan O
Cells; 2023 Aug; 12(16):. PubMed ID: 37626912
[TBL] [Abstract][Full Text] [Related]
19. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
20. Collaborative Regulation of LRG1 by TGF-β1 and PPAR-β/δ Modulates Chronic Pressure Overload-Induced Cardiac Fibrosis.
Liu C; Lim ST; Teo MHY; Tan MSY; Kulkarni MD; Qiu B; Li A; Lal S; Dos Remedios CG; Tan NS; Wahli W; Ferenczi MA; Song W; Hong W; Wang X
Circ Heart Fail; 2019 Dec; 12(12):e005962. PubMed ID: 31830829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
